Clinical Trials Directory

Trials / Completed

CompletedNCT04905446

Measurement of NAD+ Synthesis in Human Skeletal Muscle

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
AdventHealth Translational Research Institute · Academic / Other
Sex
Male
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

The key objective of this pilot research study is to dose human volunteers with a heavy (non-radioactive) isotope derivative of nicotinamide to detect NAD synthesis in human skeletal muscle. The ultimate goal is to examine the impact of lifestyle choices, aging, nutraceuticals, and drugs on the rate of NAD synthesis in human subjects.

Conditions

Interventions

TypeNameDescription
OTHERDeuterated nicotinamide (D4-NAM) IV infusionNicotinamide adenine dinucleotide (NAD) is a vitally important substance that is found in all cells of the body. D4-NAM (in normal saline) will be infused via an indwelling catheter.The IV infusion will continue for 8 hrs.
PROCEDURESkeletal muscle biopsyParticipants will have a muscle biopsy performed on the muscle in the thigh. We will collect a small sample of blood before the biopsy. This procedure is used to sample muscle cells from the right or left leg Vastus Lateralis (thigh) muscle.
PROCEDURESkin tissue biopsyThis procedure is used to sample skin tissue from the upper thigh via a punch biopsy.

Timeline

Start date
2021-09-10
Primary completion
2022-06-14
Completion
2024-12-20
First posted
2021-05-27
Last updated
2025-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04905446. Inclusion in this directory is not an endorsement.